For updates and more in-depth analysis from David Fried, please click here.
For updates and more in-depth analysis from Kelly Wright, please click here.
For updates and more in-depth analysis from Peter Way, please click here.
For updates and more in-depth analysis from Dan Sullivan, please click here.
For updates and more in-depth analysis from Tom Bishop, please click here.
For updates and more in-depth analysis from David Kliff, please click here.
For updates and more in-depth analysis from Curtis Hesler, please click here.
For the bearish case on home builders from Forbes Special Situation Survey, please click here.
For updates and more in-depth analysis from Gerald and Marvin Appel, please click here.
For updates and more in-depth analysis from Michael Markowski's StockDiagnostics, please click here.
For updates and more in-depth analysis from Ken Kam and the Marketocracy M100, please click here.
To read my brief reflection from the 2011 Skoll World Forum earlier this year, please click here.
FORBES: A Minute with Jeff Skoll on Technology and Global Social Change
For updates and analysis from Timothy and Carlton Lutts' Cabot Market Letter and Cabot's Sector Inspector, please click here.
That ruling prompted calls from consumer advocates for the FDA to change its regulations, which the agency is now considering doing ( please look here).
FORBES: Good For Generic Drugmakers? White House To Argue In Favor Of Preemption
应用推荐